Literature DB >> 33141628

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2020        PMID： 33141628      PMCID： PMC7644244          DOI： 10.1080/21645515.2020.1829897

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  1 in total

1.  First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.

Authors:  Pauline Verdijk; Johan L van der Plas; Emilie M J van Brummelen; Rienk E Jeeninga; Cornelis A M de Haan; Meta Roestenberg; Jacobus Burggraaf; Ingrid M C Kamerling
Journal:  Vaccine       Date:  2020-07-25       Impact factor: 3.641
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.